Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis
|
journal
|
April 2011 |
Increased Immunoaccessibility of MOMP Epitopes in a Vaccine Formulated with Amphipols May Account for the Very Robust Protection Elicited against a Vaginal Challenge with Chlamydia muridarum
|
journal
|
April 2014 |
Identification of Plasmid-Free Chlamydia muridarum Organisms Using a Pgp3 Detection-Based Immunofluorescence Assay
|
journal
|
October 2015 |
DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice
|
journal
|
March 2003 |
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
|
journal
|
October 2019 |
Identification of Immunodominant Antigens by Probing a WholeChlamydia trachomatisOpen Reading Frame Proteome Microarray Using Sera from Immunized Mice
|
journal
|
January 2011 |
Trachoma: A Blinding Scourge from the Bronze Age to the Twenty‐First Century:Trachoma: A Blinding Scourge from the Bronze Age to the Twenty‐First Century
|
journal
|
March 2009 |
Classification of Trachoma Virus Strains by Protection of Mice from Toxic Death
|
journal
|
June 1963 |
Chlamydia muridarumT-Cell Antigens Formulated with the Adjuvant DDA/TDB Induce Immunity against Infection That Correlates with a High Frequency of Gamma Interferon (IFN-γ)/Tumor Necrosis Factor Alpha and IFN-γ/Interleukin-17 Double-Positive CD4+T Cells
|
journal
|
May 2010 |
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?
|
journal
|
April 2021 |
Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen
|
journal
|
April 2016 |
A 3-Dimensional Trimeric β-Barrel Model for Chlamydia MOMP Contains Conserved and Novel Elements of Gram-Negative Bacterial Porins
|
journal
|
July 2013 |
Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein
|
journal
|
August 2009 |
Characterization of Pgp3, aChlamydia trachomatisPlasmid-Encoded Immunodominant Antigen
|
journal
|
November 2010 |
Chlamydia trachomatis Polymorphic Membrane Proteins (Pmps) Form Functional Homomeric and Heteromeric Oligomers
|
journal
|
July 2021 |
Studies on Trachoma
|
journal
|
July 1966 |
Diversity of Chlamydia trachomatis major outer membrane protein genes
|
journal
|
September 1987 |
Immunotyping of Chlamydia trachomatis with Monoclonal Antibodies
|
journal
|
October 1985 |
Reduced Antigenicity of Naturally Occurring Hepatitis B Surface Antigen Variants with Substitutions at the Amino Acid Residue 126
|
journal
|
January 2008 |
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis
|
journal
|
March 1981 |
Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers
|
journal
|
December 2015 |
The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol ofChlamydia-Infected Cells
|
journal
|
August 2008 |
Structure of the Chlamydia trachomatis Immunodominant Antigen Pgp3
|
journal
|
July 2013 |
Is the Increase in Notifications of Chlamydia trachomatis Infections in Sweden the Result of Changes in Prevalence, Sampling Frequency or Diagnostic Methods?
|
journal
|
January 2002 |
Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections
|
journal
|
October 2009 |
A common plasmid of Chlamydia trachomatis
|
journal
|
July 1986 |
Variable expression of surface-exposed polymorphic membrane proteins inin vitro-grownChlamydia trachomatis
|
journal
|
February 2010 |
Comparative Expression Profiling of the Chlamydia trachomatis pmp Gene Family for Clinical and Reference Strains
|
journal
|
September 2007 |
Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity
|
journal
|
April 1988 |
Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer
|
journal
|
January 2012 |
Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein
|
journal
|
November 1982 |
Structural and Functional Analyses of the Major Outer Membrane Protein of Chlamydia trachomatis
|
journal
|
June 2007 |
Plasmid-Encoded Pgp3 Is a Major Virulence Factor for Chlamydia muridarum To Induce Hydrosalpinx in Mice
|
journal
|
December 2014 |
Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms: Quantitative proteomics analysis of C. trachomatis developmental forms
|
journal
|
November 2011 |
Chlamydia trachomatis Screening and Treatment in Pregnancy to Reduce Adverse Pregnancy and Neonatal Outcomes: A Review
|
journal
|
June 2021 |
Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates
|
journal
|
December 2015 |
Chlamydia vaccine candidates and tools for chlamydial antigen discovery
|
journal
|
October 2009 |
Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants
|
journal
|
October 2008 |
Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582)
|
journal
|
February 2014 |
A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility
|
journal
|
August 2019 |
Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.
|
journal
|
March 1989 |
Development of aChlamydia trachomatisvaccine for urogenital infections: novel tools and new strategies point to bright future prospects
|
journal
|
December 2017 |
Induction of Cross-Serovar Protection against Genital Chlamydial Infection by a Targeted Multisubunit Vaccination Approach
|
journal
|
December 2007 |
Chlamydial Infections
|
journal
|
February 1978 |
Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection
|
journal
|
December 1994 |
Profiling of Human Antibody Responses toChlamydia trachomatisUrogenital Tract Infection Using Microplates Arrayed with 156 Chlamydial Fusion Proteins
|
journal
|
March 2006 |
Seventy Years of Chlamydia Vaccine Research – Limitations of the Past and Directions for the Future
|
journal
|
January 2019 |
Trachoma Vaccine Studies in Monkeys
|
journal
|
May 1967 |
Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge
|
journal
|
May 2017 |
Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner
|
journal
|
June 2008 |
Chlamydia Public Health Programs and the Epidemiology of Pelvic Inflammatory Disease and Ectopic Pregnancy
|
journal
|
October 2012 |
Vaccination against Chlamydia Genital Infection Utilizing the Murine C. muridarum Model
|
journal
|
March 2011 |
Expression, Processing, and Localization of PmpD of Chlamydia trachomatis Serovar L2 during the Chlamydial Developmental Cycle
|
journal
|
June 2007 |
Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine
|
journal
|
June 2009 |
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice
|
journal
|
July 2016 |
Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of
Chlamydia trachomatis
vaccines
|
journal
|
May 2011 |
Chlamydiavaccines: recent developments and the role of adjuvants in future formulations
|
journal
|
November 2011 |
Antigenic Analysis of the Major Outer Membrane Protein of Chlamydia spp
|
journal
|
March 1982 |
Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of Chlamydia
|
journal
|
July 2016 |
A Genome-Wide Profiling of the Humoral Immune Response to Chlamydia trachomatis Infection Reveals Vaccine Candidate Antigens Expressed in Humans
|
journal
|
August 2010 |
Chlamydia trachomatispolymorphic membrane protein D is a species-common pan-neutralizing antigen
|
journal
|
January 2006 |
Immunoproteomic Discovery of Novel T Cell Antigens from the Obligate Intracellular Pathogen Chlamydia
|
journal
|
February 2008 |
Identification and characterization of novel recombinant vaccine antigens for immunization against genitalChlamydia trachomatis
|
journal
|
March 2009 |
Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice
|
journal
|
November 2008 |
Chlamydia trachomatisPolymorphic Membrane Protein D Is an Oligomeric Autotransporter with a Higher-Order Structure
|
journal
|
January 2009 |
Chlamydia trachomatis
-Infected Patients Display Variable Antibody Profiles against the Nine-Member Polymorphic Membrane Protein Family
|
journal
|
August 2009 |
Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis
|
journal
|
August 1994 |
Field Trial of A Monovalent and of A Bivalent Mineral Oil Adjuvant Trachoma Vaccine in Taiwan School Children
|
journal
|
May 1967 |
Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis
|
journal
|
October 1998 |
The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism
|
journal
|
March 1990 |
Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant
|
journal
|
June 2020 |
Proteomic identification of immunodominant chlamydial antigens in a mouse model
|
journal
|
December 2012 |
Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology
|
journal
|
May 2017 |
Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine
|
journal
|
June 2011 |
Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine
|
journal
|
February 2005 |
The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018
|
journal
|
January 2021 |
Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge
|
journal
|
March 2011 |
Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice
|
journal
|
March 2019 |
Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria
|
journal
|
November 2005 |
Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine
|
journal
|
July 2011 |
Identification of a
Chlamydia trachomatis
Serovar E Urogenital Isolate Which Lacks the Cryptic Plasmid
|
journal
|
December 1998 |
Evaluating Potential Vaccine Antigens in both the <i>Chlamydia trachomatis</i> and <i>Chlamydia muridarum</i> Intravaginal Mouse Challenge Models
|
journal
|
January 2019 |